Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 1

Status

Completed 4Terminated 1

Sponsor Class

OTHER 2NIH 2

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 2Tumor-Agnostic 1Thoracic 1Gynecologic 1Genitourinary 1

Conditions

Breast Neoplasms 2Uterine Cervical Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Lung Neoplasms 1Kidney Neoplasms 1

Interventions

Cyclophosphamide 641Bevacizumab 552Paclitaxel 534Carboplatin 533Cisplatin 480pembrolizumab 456Gemcitabine 422Docetaxel 415Rituximab 386Radiotherapy 373Dexamethasone 351Doxorubicin 330Nivolumab 308Fluorouracil 286Capecitabine 260Etoposide 245Prednisone 244Oxaliplatin 242Erlotinib Hydrochloride 242Cytarabine 233Lenalidomide 232Trastuzumab 226Pemetrexed 220Vincristine 212fludarabine phosphate 208Leucovorin 208Cetuximab 208Filgrastim 204Bortezomib 193Methotrexate 183

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Has results × Technetium Tc 99m Sestamibi × Clear all
NCT01925170 2014-08-19

Low Dose Molecular Breast Imaging as a Screening Tool for Women With Dense Breasts

Mayo Clinic

Phase NA Completed
1,638 enrolled 15 charts
Breast

Breast Neoplasms

NCT00620373 2014-08-01

Molecular Breast Imaging as a Screening Tool for Women With Dense Breasts

Mayo Clinic

Phase NA Completed
969 enrolled 12 charts
Breast

Breast Neoplasms

NCT00069160 2012-10-12

Tariquidar and Docetaxel to Treat Patients With Lung, Ovarian, Renal and Cervical Cancer

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
48 enrolled 13 charts
GenitourinaryGynecologicThoracic

Uterine Cervical Neoplasms, Kidney Neoplasms, Lung Neoplasms, Ovarian Neoplasms

NCT00972205 2012-07-19

Paclitaxel and CBT-1(Registered Trademark) to Treat Solid Tumors

National Institutes of Health Clinical Center (CC)

Phase NA Completed
12 enrolled 12 charts
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡